Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2014

Lee Hyun-Ju, Choi Nu-Ri, Vo Manh-Cuong, Hoang My-Dung, Lee Youn-Kyung, Lee Je-Jung

Abstract excerpt

Cancer immunotherapy based on dendritic cell (DC) vaccination has promising alternatives for the treatment of cancer. A central tenet of DC-based cancer immunotherapy is the generation of antigen-specific cytotoxic T lymphocyte (CTL) response. Tumor-associated antigens (TAA) and DC play pivotal roles in this process. DCs are well known to be the most potent antigen-presenting cells and have the most powerful...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Culture Techniques

Share to Cell Separation

Share to Dendritic Cells

Share to HLA-A2 Antigen

Share to Protein Stability

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 24619666
DOI: 10.1007/978-1-4939-0345-0_2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.PMID 24619666Read ↗

Dendritic cells transfected with a polyepitope DNA construct stimulate an antitumor cytotoxic response in various tumor diseasesSemantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

Dendritic-Tumor Fusion Cell-Based Cancer VaccinesSemantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Semantic proximity Read ↗

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read ↗

HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.Semantic proximity Read ↗

Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapySemantic proximity Read ↗

Cancer Vaccines: Antigen Selection StrategySemantic proximity Read ↗

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor CellSemantic proximity Read ↗

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.Semantic proximity Read ↗

Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.